Literature DB >> 6871482

Heterogeneity of estrogen binding sites in mammary tumors.

J H Clark, C S Watson, B M Markaverich, J S Syne, W B Panko.   

Abstract

This paper provides a brief summary of our recent work on the heterogeneity of estradiol binding sites in mammary tumors of the mouse and human. Mammary tumors from both species contain the classical estrogen receptor and a second site(s) which we call type II. These type II sites are found in the cytoplasmic and nuclear compartments of both tumors, and can interfere with the measurement of estrogen receptors. The function of type II sites is not known; however, an assessment of these sites in conjunction with an accurate measurement of the estrogen receptor may provide a clearer picture of the true hormone dependence of breast tumors.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6871482     DOI: 10.1007/bf01806234

Source DB:  PubMed          Journal:  Breast Cancer Res Treat        ISSN: 0167-6806            Impact factor:   4.872


  8 in total

1.  A graphic method for the determination and presentation of binding parameters in a complex system.

Authors:  H E Rosenthal
Journal:  Anal Biochem       Date:  1967-09       Impact factor: 3.365

Review 2.  Female sex steroids: receptors and function.

Authors:  J H Clark; E J Peck
Journal:  Monogr Endocrinol       Date:  1979

3.  Heterogeneity of estrogen binding sites in the cytosol of the rat uterus.

Authors:  J H Clark; J W Hardin; S Upchurch; H Eriksson
Journal:  J Biol Chem       Date:  1978-11-10       Impact factor: 5.157

4.  The presence of a second, specific estrogen binding site in human breast cancer.

Authors:  W B Panko; C S Watson; J H Clark
Journal:  J Steroid Biochem       Date:  1981-12       Impact factor: 4.292

5.  Heterogeneity of estrogen binding sites in mouse mammary cancer.

Authors:  C S Watson; J H Clark
Journal:  J Recept Res       Date:  1980

6.  Estrogen binding sites in the nucleus of normal and malignant human tissue: optimization of an exchange assay for the measurement of specific binding.

Authors:  J S Syne; B M Markaverich; J H Clark; W B Panko
Journal:  Cancer Res       Date:  1982-11       Impact factor: 12.701

7.  Mathematical theory of complex ligand-binding systems of equilibrium: some methods for parameter fitting.

Authors:  H A Feldman
Journal:  Anal Biochem       Date:  1972-08       Impact factor: 3.365

8.  Heterogeneity of estrogen receptors in the cytosol and nuclear fractions of the rat uterus.

Authors:  H Eriksson; S Upchurch; J W Hardin; E J Peck; J H Clark
Journal:  Biochem Biophys Res Commun       Date:  1978-03-15       Impact factor: 3.575

  8 in total
  3 in total

1.  Long-term effects of estrogen on avian liver: estrogen-inducible switch in expression of nuclear, hormone-binding proteins.

Authors:  R J Haché; S P Tam; A Cochrane; M Nesheim; R G Deeley
Journal:  Mol Cell Biol       Date:  1987-10       Impact factor: 4.272

2.  Heterogeneity of estrogen binding sites in breast cancer: morphologic demonstration and relationship to endocrine response.

Authors:  L P Pertschuk; K B Eisenberg; A C Carter; J G Feldman
Journal:  Breast Cancer Res Treat       Date:  1985       Impact factor: 4.872

3.  Monoclonal antibody DF3 correlates with tumor differentiation and hormone receptor status in breast cancer patients.

Authors:  J Lundy; A Thor; R Maenza; J Schlom; F Forouhar; M Testa; D Kufe
Journal:  Breast Cancer Res Treat       Date:  1985       Impact factor: 4.872

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.